Key result
Exercise in ischemic cardiomyopathy improves cardiopulmonary function and QoL while reducing hospitalizations and mortality.
Why the study?
Current clinical guidelines lack specific exercise prescriptions tailored to the unique pathophysiology of ischemic cardiomyopathy.
What are the cardiovascular benefits and optimal prescriptions of exercise for patients with ischemic cardiomyopathy?
What are the cardiovascular benefits and optimal prescriptions of exercise for patients with ischemic cardiomyopathy?
This scoping review highlights the benefits of exercise in ischemic cardiomyopathy and identifies a critical gap in current guidelines regarding specific exercise prescriptions.
Supports exercise benefits in ischemic cardiomyopathy; leaves open specific prescriptions and prospective trials.
This review explores the critical role of exercise as a non-pharmacological intervention in managing ischemic cardiomyopathy (ICM), a leading cause of heart failure. It highlights the profound cardiovascular benefits of exercise, such as improved cardiopulmonary parameters, decreased morbidity and mortality, and enhanced functional capacity. It also critically evaluates existing literature on the efficacy of various exercise types and intensities, including aerobic, resistance, and high-intensity interval training. There is a significant gap in current clinical guidelines, which lack specific exercise prescriptions tailored to the unique pathophysiology of ICM. By synthesizing data from both older and contemporary studies, this review highlights specific, evidence-based exercise regimens and promotes supervised cardiac rehabilitation programs. This review also addresses potential barriers to cardiac rehabilitation participation and proposes future directions, which include the use of technology to improve adherence and outcomes.
No takes yet. Share an insight, caveat, or question.
Koskina et al. (2025) conducted a review in Ischemic cardiomyopathy. Exercise training and cardiac rehabilitation was evaluated. Exercise interventions in patients with ischemic cardiomyopathy improve sympathovagal tone, cardiopulmonary function, and quality of life, while reducing hospitalization rates and mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: